ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo could boost survival in leukemia transplant patients
Disease control Recruiting nowThis study compares two different drug combinations given before a stem cell transplant to adults with acute myeloid leukemia (AML) that's in remission. Researchers want to see if one combination (clofarabine/busulfan) helps patients live longer without the cancer returning compa…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted radiation and transplant tested as lifeline for tough blood cancers
Disease control Recruiting nowThis study is testing a new treatment for adults with high-risk or hard-to-treat blood cancers like leukemia. The treatment involves a radioactive antibody designed to target cancer cells, followed by a stem cell transplant from a partially matched family donor. The main goals ar…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Could a gentler drug schedule keep leukemia at bay?
Disease control Recruiting nowThis study is testing if a shorter, 14-day cycle of the drug venetoclax is easier for patients to tolerate while still keeping their acute myeloid leukemia (AML) in remission. It is for 41 adults with AML who are in remission but cannot receive intensive treatments like stem cell…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to stop blood Cancer's comeback after transplant
Disease control Recruiting nowThis early-stage study is testing whether adding an experimental drug called ziftomenib to standard care after a bone marrow transplant is safe and can help keep acute myeloid leukemia (AML) from coming back. The study will enroll about 22 adults with specific genetic types of AM…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC